Report of the results of a double-blind, randomized, single-dose trial of a topical 2% escin gel versus placebo in the acute treatment of experimentally-induced hematoma in volunteers.

The efficiency of topically applied 2% escin gel in reducing tenderness to pressure on experimentally induced hematoma is demonstrated. A double-blind, randomized signal dose trial versus placebo in healthy volunteers was used.

RCT Entities:   Population Interventions Outcomes